Project 3

项目3

基本信息

项目摘要

PROJECT SUMMARY Lyme disease is the most prevalent arthropod-borne disease in the US with more that 30,000 cases reported to the Centers for Disease Control and Prevention in 2010. The causative agent of the disease is Borrelia burgdorferi (Bb) and is transmitted to humans by the bite of infected ticks. Treatment with antibiotics during the initial stage of the disease is effective, although about 25% of the patients treated with antibiotics continue to suffer from arthritis and other post- Lyme disease syndromes; of those patients treated for neuroborreliosis, many experience lingering symptoms including memory impairment and changes in cognition. Recently, our laboratory has demonstrated that 1) Bb can be detected in the brains of infected rats; 2) Bb can cause neuroinflammatory changes in the brain that recapitulate those seen in human patients and nonhuman primate models; and 3) antibiotic-killed Bb can induce an inflammatory response in the brain, suggesting that dead microorganisms and spirochetal debris that remain after antibiotic treatment can contribute to neural pathology. Our central hypothesis is that Lyme neuroborreliosis results from a sustained Bb-induced neuroinflammatory response in the absence of live microorganisms. We believe that the inflammation and lingering symptoms of neuroborreliosis are due to the persistence of bacterial debris following antibiotic treatment. We have generated several reagents and methodologies to test this hypothesis with 3 Specific Aims. In Specific Aim 1 we will characterize the extent of antibiotic-killed Bb-induced inflammation and persistence of spirochetal debris in the brains of rats. In the second Specific Aim we will quantify neuronal apoptosis and cognitive deficits caused by antibiotic-killed Bb. Finally, in Specific Aim 3 we will determine the signaling pathways mediating Bb-induced neuroinflammation and apoptosis. Our findings will contribute to the knowledge base necessary for the development of intervention strategies for prevention and potentially treatment of post-Lyme disease neurological syndromes.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Catherine Ayn Brissette其他文献

Mutation of the peptide-regulated transcription factor ComR for amidated peptide specificity and heterologous function in emLactiplantibacillus plantarum/em WCFS1
用于植物乳杆菌 WCFS1 中酰胺化肽特异性和异源功能的肽调节转录因子 ComR 的突变
  • DOI:
    10.1128/spectrum.00517-24
  • 发表时间:
    2024-04-22
  • 期刊:
  • 影响因子:
    3.800
  • 作者:
    Michael Brasino;Eli Wagnell;E. Sila Ozdemir;Srivathsan Ranganathan;Justin Merritt;Catherine Ayn Brissette
  • 通讯作者:
    Catherine Ayn Brissette

Catherine Ayn Brissette的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Catherine Ayn Brissette', 18)}}的其他基金

Yersina perstis interactions with macrophages
持久耶尔森氏菌与巨噬细胞的相互作用
  • 批准号:
    11007413
  • 财政年份:
    2023
  • 资助金额:
    $ 24.99万
  • 项目类别:
Bacterial and host factors in the pathogenesis of Lyme neuroborreliosis
莱姆神经疏螺旋体病发病机制中的细菌和宿主因素
  • 批准号:
    10652565
  • 财政年份:
    2022
  • 资助金额:
    $ 24.99万
  • 项目类别:
Bacterial and host factors in the pathogenesis of Lyme neuroborreliosis
莱姆神经疏螺旋体病发病机制中的细菌和宿主因素
  • 批准号:
    10443463
  • 财政年份:
    2022
  • 资助金额:
    $ 24.99万
  • 项目类别:
Borrelia miyamotoi meningioencephalitis
宫本疏螺旋体脑膜脑炎
  • 批准号:
    10078262
  • 财政年份:
    2020
  • 资助金额:
    $ 24.99万
  • 项目类别:
MicroRNAs induced in response to Borrelia burgdorferi
响应伯氏疏螺旋体诱导的 MicroRNA
  • 批准号:
    9164595
  • 财政年份:
    2016
  • 资助金额:
    $ 24.99万
  • 项目类别:
Role of Borrelia burgdorferi Rev fibronectin binding proteins in Lyme disease
伯氏疏螺旋体 Rev 纤连蛋白结合蛋白在莱姆病中的作用
  • 批准号:
    8089914
  • 财政年份:
    2011
  • 资助金额:
    $ 24.99万
  • 项目类别:
Role of Borrelia burgdorferi Rev fibronectin binding proteins in Lyme disease
伯氏疏螺旋体 Rev 纤连蛋白结合蛋白在莱姆病中的作用
  • 批准号:
    8318658
  • 财政年份:
    2011
  • 资助金额:
    $ 24.99万
  • 项目类别:
Role of a Borrelia burgdorferi fibronection-binding protein in Lyme Disease
伯氏疏螺旋体纤维连接结合蛋白在莱姆病中的作用
  • 批准号:
    8008810
  • 财政年份:
    2009
  • 资助金额:
    $ 24.99万
  • 项目类别:
Project 3
项目3
  • 批准号:
    9924574
  • 财政年份:
  • 资助金额:
    $ 24.99万
  • 项目类别:
Project 3
项目3
  • 批准号:
    9273570
  • 财政年份:
  • 资助金额:
    $ 24.99万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 24.99万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.99万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 24.99万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.99万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 24.99万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 24.99万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.99万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 24.99万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 24.99万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.99万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了